Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (228)
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
30,000
Price
$96.22
Total Value
$2.89M
Shares Held After
489,209
% of Holdings
5.8%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
35,852
Price
$43.05
Total Value
$1.54M
Shares Held After
13,115
% of Holdings
73.2%
CRESCENT BIOPHARMA, INC. (CBIO)
Brumm Joshua T — Director
Shares
7,837
Price
$16.71
Total Value
$130.96K
Shares Held After
271,765
% of Holdings
2.8%
CRESCENT BIOPHARMA, INC. (CBIO)
McNeill Jonathan — President and COO
Shares
3,839
Price
$16.71
Total Value
$64.15K
Shares Held After
134,588
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$501.60
Total Value
$80.26K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
468
Price
$500.09
Total Value
$234.04K
Shares Held After
324,603
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
332
Price
$499.10
Total Value
$165.70K
Shares Held After
325,071
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
151
Price
$497.79
Total Value
$75.17K
Shares Held After
325,403
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,953
Price
$497.17
Total Value
$970.98K
Shares Held After
325,554
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,182
Price
$496.21
Total Value
$1.08M
Shares Held After
327,507
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,905
Price
$495.11
Total Value
$943.18K
Shares Held After
329,689
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,750
Price
$494.34
Total Value
$865.10K
Shares Held After
331,594
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
599
Price
$493.22
Total Value
$295.44K
Shares Held After
333,344
% of Holdings
0.2%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
34,000
Price
$98.60
Total Value
$3.35M
Shares Held After
519,209
% of Holdings
6.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
320
Price
$501.58
Total Value
$160.51K
Shares Held After
45,172
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
125
Price
$500.80
Total Value
$62.60K
Shares Held After
45,492
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,160
Price
$499.75
Total Value
$579.71K
Shares Held After
45,617
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
843
Price
$498.74
Total Value
$420.44K
Shares Held After
46,777
% of Holdings
1.8%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
700
Price
$104.39
Total Value
$73.07K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,400
Price
$497.54
Total Value
$696.56K
Shares Held After
47,620
% of Holdings
2.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
1,100
Price
$103.20
Total Value
$113.52K
Shares Held After
700
% of Holdings
61.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
2,873
Price
$496.58
Total Value
$1.43M
Shares Held After
49,020
% of Holdings
5.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
3,501
Price
$102.39
Total Value
$358.47K
Shares Held After
1,800
% of Holdings
66.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,579
Price
$495.97
Total Value
$783.13K
Shares Held After
51,893
% of Holdings
3.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
6,771
Price
$101.37
Total Value
$686.38K
Shares Held After
5,301
% of Holdings
56.1%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
7,928
Price
$100.43
Total Value
$796.21K
Shares Held After
12,072
% of Holdings
39.6%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
376
Price
$68.45
Total Value
$25.74K
Shares Held After
1,296,594
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
9,624
Price
$67.83
Total Value
$652.80K
Shares Held After
1,296,970
% of Holdings
0.7%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
800
Price
$43.00
Total Value
$34.40K
Shares Held After
13,115
% of Holdings
5.7%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
24,000
Price
$0.21
Total Value
$4.99K
Shares Held After
126,822
% of Holdings
18.9%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
6,802
Price
$64.95
Total Value
$441.80K
Shares Held After
432,886
% of Holdings
1.5%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
101,691
Price
$64.59
Total Value
$6.57M
Shares Held After
439,688
% of Holdings
18.8%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
8,282
Price
$65.07
Total Value
$538.92K
Shares Held After
117,066
% of Holdings
6.6%
Caris Life Sciences, Inc. (CAI)
Brille Brian J — Director
Shares
400,000
Price
$30.33
Total Value
$12.13M
Shares Held After
230,303
% of Holdings
63.5%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,654
Price
$153.24
Total Value
$253.46K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
989
Price
$152.36
Total Value
$150.69K
Shares Held After
1,654
% of Holdings
37.4%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,659
Price
$151.16
Total Value
$250.77K
Shares Held After
2,643
% of Holdings
38.6%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
3,674
Price
$25.00
Total Value
$91.85K
Shares Held After
112,508
% of Holdings
3.2%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
7,869
Price
$28.57
Total Value
$224.82K
Shares Held After
220,867
% of Holdings
3.4%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
107,537
Price
$28.02
Total Value
$3.01M
Shares Held After
228,736
% of Holdings
32.0%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
296
Price
$100.82
Total Value
$29.84K
Shares Held After
3,946
% of Holdings
7.0%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
1,285
Price
$1.91
Total Value
$2.45K
Shares Held After
5,616
% of Holdings
18.6%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
32,607
Price
$1.91
Total Value
$62.28K
Shares Held After
142,463
% of Holdings
18.6%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
1,747
Price
$199.30
Total Value
$348.18K
Shares Held After
42,116
% of Holdings
4.0%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
27
Price
$195.05
Total Value
$5.27K
Shares Held After
43,863
% of Holdings
0.1%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Shares
5,484
Price
$199.30
Total Value
$1.09M
Shares Held After
286,307
% of Holdings
1.9%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
336
Price
$199.30
Total Value
$66.97K
Shares Held After
52,868
% of Holdings
0.6%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Shares
85
Price
$195.01
Total Value
$16.58K
Shares Held After
291,791
% of Holdings
0.0%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
5
Price
$194.96
Total Value
$974.79
Shares Held After
53,204
% of Holdings
0.0%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
4,891
Price
$199.30
Total Value
$974.79K
Shares Held After
149,680
% of Holdings
3.2%
Showing 1–50 of 228 transactions (page 1 of 5)